← All Investors
LAVA THERAPEUTICS NV
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q4 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$83K | ~$1.56 |
| Q3 2025 | Ken Griffin - Citadel Advisors | SELL | −$25K | ~$1.56 |
| Q2 2025 | Ken Griffin - Citadel Advisors | BUY | +$19K | ~$1.32 |
| Q1 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$70K | ~$1.27 |
| Q1 2025 | Israel Englander - Millennium Management | SOLD OUT | −$18K | ~$0.95 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SOLD OUT | −$40K | ~$1.66 |
| Q4 2024 | Israel Englander - Millennium Management | BUY | +$7K | ~$0.95 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SELL | −$151K | ~$1.66 |
| Q3 2024 | Israel Englander - Millennium Management | SELL | −$23K | ~$1.66 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$207K | ~$1.80 |
| Q2 2024 | Israel Englander - Millennium Management | NEW BUY | +$47K | ~$1.80 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q3 2025 | 1 | 53,308 | −23.4% | $83K | $1.56 |
| Q2 2025 | 1 | 69,604 | +26.3% | $91K | $1.32 |
| Q1 2025 | 1 | 55,123 | +181.2% | $70K | $1.27 |
| Q4 2024 | 1 | 19,604 | −46.0% | $18K | $0.95 |
| Q3 2024 | 2 | 36,276 | −74.4% | $60K | $1.66 |
| Q2 2024 | 2 | 141,930 | — | $255K | $1.80 |